|
Magyar Kardiológusok Társasága |
|
ESC Congress 2014 |
Rendezvény kezdete: 2014.08.30. | Rendezvény vége: 2014.09.03. |
Helyszín: Spanyolország, 08908 Barcelona, Av. Joan Carles I, 64, Congress centre Fira Gran Via 2 |
A rendezvény Web oldala: http://www.escardio.org/congresses/esc-2014/Pages/welcome.aspx? |
Innovation and the Heart:
The spotlight of this year's congress captures innovations in scientific discovery, clinical practice, technology, education and importantly in applications to clinical care.
Cardiology is evolving rapidly and it is critically important to keep up to date, not only in the areas of our special interests but also in what is happening elsewhere across the spectrum of cardiovascular disease.
Make sure to submit your abstract before 14 February 2014 (Midnight CET).
Aged 36 and under? Submit your most challenging clinical case before 1 March 2014 |
|
|
 |
|
Magyar Immunológiai Társaság |
|
DC2012 - 12th International Symposium on Dendritic Cells |
Rendezvény kezdete: 2012.10.07. | Rendezvény vége: 2012.10.11. |
Munkahely neve: DC 2012 Secretariat |
Címe: 1F Haeoreum B/D 748-5 Yeoksam-dong
Gangnam-gu Seoul 135-925 Korea |
Tel: +82-2-577-8422,8423 |
Fax: +82-2-566-6087 |
E-mail: dc@people-x.com |
Helyszín: Korea, Daegu, EXCO Convention Center |
A rendezvény Web oldala: http://www.dc2012.kr/ |
The 12th International Symposium on Dendritic Cells
The DC2012 is hosted by the Korean Association of Immunologists and organized by the
Organizing Committee of the DC 2012.
The DC 2012 is anticipating more than 1,600 participants and industry representatives from 40
different countries. I truly believe that DC2012 would be the milestone for all of us to understand the
cutting-edge of research trends, to share valuable information and to build a network between
specialists in the field of dendritic cells.
Deadline of Abstract Submission is extended to June 30, 2012
re-registration: Extended to Sep. 14th, 2012!
Clinical Trial Satellite Meeting(Sponsored by JW CreaGene, BD)
*Date & Time: October 8~9, 2012 / 12:20~13:20
*Venue: 4F Auditorium, EXCO
*Confirmed Speakers:
1)TriMix Dentritic cell therapy in Melanoma - the Brussels`s experience
-Prof. Thielemans Kris (Vrije Universiteit Brussel, Belgium)
2)Applying Lessons learned from Provenge to the development of new immunotherapies for cancer
-Dr. James B. Trager (Dendreon Corporation, USA)
-The lunch will be served during the Clinical Trial Satellite Meeting.
-Maximum 300 persons can attend the meeting on a first-come, first-served basis. |
|
|
 |